Pfizer Chief Calls Patent Pool ‘Nonsense’, Fears Tussle Over Vaccine
Big Pharma Pledges No Profits During Pandemic, But Will Not Relinquish IP
Executive Summary
Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.
You may also be interested in...
Coronavirus Update: GSK Stresses Need For Broad Vaccines Amid Future Pandemic Risk
Also, Neoimmune looks to interleukin therapy for mild therapy while Daiichi Sankyo bets on a mRNA vaccine.
Coronavirus Update: White House Picks Five Vaccines For US Operation Warp Speed
An official announcement is expected within weeks, as competition between US and China stokes fears of 'vaccine nationalism'.
WHO Launches COVID-19 Technology Access Pool
C-TAP, the voluntary initiative aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all, has been launched by the WHO, in partnership with Costa Rica.